208 related articles for article (PubMed ID: 7097294)
1. [3H]Spiperone labels non-cyclase-linked dopamine receptors in the ventral tegmental area of rat brain.
Gundlach AL; McDonald D; Beart PM
J Neurochem; 1982 Sep; 39(3):890-4. PubMed ID: 7097294
[TBL] [Abstract][Full Text] [Related]
2. Neurochemical studies of the mesolimbic dopaminergic pathway: [3H]spiperone labels two bindings sites in homogenates of the nucleus accumbens of rat brain.
Beart PM; McDonald D
J Neurochem; 1982 Nov; 39(5):1452-60. PubMed ID: 6126526
[TBL] [Abstract][Full Text] [Related]
3. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
Lazareno S; Nahorski SR
Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
[TBL] [Abstract][Full Text] [Related]
4. A neuroblastoma clone which has dopamine-sensitive adenylate cyclase but which lacks stereospecific binding sites for the neuroleptic [3H]spiperone.
Hartley EJ; Spuhler K; Prasad KN; Seeman P
Brain Res; 1980 May; 190(2):574-7. PubMed ID: 6154511
[No Abstract] [Full Text] [Related]
5. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
6. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
Gundlach AL; Largent BL; Snyder SH
Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
[TBL] [Abstract][Full Text] [Related]
7. Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain.
Quik M; Iversen LL
Eur J Pharmacol; 1979 Jul; 56(4):323-30. PubMed ID: 477728
[No Abstract] [Full Text] [Related]
8. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
Beart PM; Krstich M; McDonald D; Gundlach AL
Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors in the goldfish retina: 3H-spiroperidol and 3H-domperidone binding; and dopamine-stimulated adenylate cyclase activity.
Redburn DA; Clement-Cormier Y; Lam DM
Life Sci; 1980 Jul; 27(1):23-31. PubMed ID: 6105607
[No Abstract] [Full Text] [Related]
10. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
[No Abstract] [Full Text] [Related]
11. [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor.
Battaglia G; Titeler M
Eur J Pharmacol; 1982 Jul; 81(3):493-8. PubMed ID: 6126376
[TBL] [Abstract][Full Text] [Related]
12. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
Köhler C; Ogren SO; Haglund L; Angeby T
Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
[TBL] [Abstract][Full Text] [Related]
13. 3H-Spiroperidol binding and dopamine-stimulated adenylate cyclase: evidence for multiple classes of receptors in primate brain regions.
Thal LJ; Makman MH; Ahn HS; Mishra RK; Horowitz SG; Dvorkin B; Katzman R
Life Sci; 1978 Aug; 23(6):629-33. PubMed ID: 99609
[No Abstract] [Full Text] [Related]
14. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
15. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
16. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
18. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
[No Abstract] [Full Text] [Related]
19. [3H]spiroperidol identifies a D-2 dopamine receptor inhibiting adenylate cyclase activity in the intermediate lobe of the rat pituitary gland.
Frey EA; Cote TE; Grewe CW; Kebabian JW
Endocrinology; 1982 Jun; 110(6):1897-904. PubMed ID: 7075543
[TBL] [Abstract][Full Text] [Related]
20. Interaction of pergolide with central dopaminergic receptors.
Goldstein M; Lieberman A; Lew JY; Asano T; Rosenfeld MR; Makman MH
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3725-8. PubMed ID: 6932044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
